meminkorkmaz@gmail.com
+90 549 427 77 71 +90 312 427 77 71

Araştırma Yazıları – Yurtdışı Yayınlar

Korkmaz M.E., Oto A., Saraçlar Y., Oram E., Oram A., Uğurlu Ş., Karamehmetoğlu A., Karaağaoğlu E. Levels of IgE in the Serum of Patients with Coronary Arterial Disease. Int J Cardiol 1991;31:199-204

Oto A., Müderrisoğlu H., Özin M.B., Korkmaz M.E., Karamehmetoğlu A., Oram A., Oram E., Uğurlu Ş. Quality of Life in Patients with Rate Responsive Pacemakers: A Randomized Cross-Over Study. PACE 1991;14:800-806

Korkmaz M.E., Arık N., Oto A., Turgan Ç., Yasavul Ü., Çağlar Ş., Işımer A., Sayar A. Cadmium, Hypertension and Smoking. Nephron 1992;60:116

Korkmaz M.E., Mahmarian J.J., Guidry G.W., Verani M.S. Safety of single-site adenosine thallium-201 scintigraphy. Am J Cardiol 1994;73:200-204

Korkmaz M.E., Müderrisoğlu H., Özdemir F.N., Kayataş M., Ertürk A. QT Interval Lengthening During Haemodialysis: Is There a Potential Risk for Torsade de Pointes? Nephrol Dial Transplant 1997;12(2):365

Kayataş M., Ertürk A., Müderrisoğlu H., Korkmaz M.E., Özdemir F.N. Acetate Hemodialysis Does Not Increase the Frequency of Arrhythmia in Hemodialysis Patients. Artificial Organs 1998;22(9):781-807

Korkmaz M.E., Çekin A.H. Bone Marow Suppression And Klebsiella Pneumonia Septicemia Due To Ticlopidine And Successful Treatment With Filgrastim; A Case Report. In J Cardiol 1998;66:317-318

Arslan H., Korkmaz M.E., Kart H., Gül Ç. Management of Brucella Endocarditis of a Prosthetic Valve. Journal of Infect. 1998;37(1):70-71

Kayataş M., Müderrisoğlu H., Özdemir F.N., Korkmaz M.E. Diastolic Dysfunction Increases the Frequency of Ventricular Arrhythmia in Hemodialysis Patients. Nephron 1999;82:185-187.

Taşkın O., Gökdeniz R., Müderrisoğlu H., Korkmaz M.E., Uryan İ., Atmaca R., Kafkaslı A. The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women. Human Reproduction 1998;13(9): 2399‑2401

Özdemir R, Yorulmaz A, Kutlu R, Guven A, Aladag M, Sezgin A, Korkmaz M.E., Muderrisoglu HLoss of nocturnal decline of blood pressure in patients with nasal polyposis. Blood Press. 1999;8(3):165-71.

Özdemir R., Tuncer C., Aladağ M., Güven A., Sezgin A.T., Pekdemir H., Korkmaz M.E., Müderrisoğlu H. Effect of Trimetazidine on Late Potentials After Acute Myocardial Infarction. Cardiovasc Drugs Ther 1999;13:1-5

Korkmaz M.E., Müderrisoğlu H., Uluçam M., Özin B. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol 2000; 86 : 649-653

The InTIME-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early. Eur Heart J 2000;21:2005-2013.

Yalçın F., Kaftan A., Müderrisoğlu H, Korkmaz M.E., Flachskampf F., Garcia M., Thomas J.D. Is Doppler tissue velocity during early left ventricular filling preload independent? Heart 2002 Apr;87(4):336-9

Yalçın F., El-Amrousy M., Müderrisoğlu H, Korkmaz M.E., Flachskampf F., Tuzcu M., Garcia M., Thomas J.D. Pulmonary venous flow reflect changes in left atrial hemodynamics during mitral balloon valvotomy. Angiology 2002;53:323-327

Korkmaz M.E. Tayfun E., Müderrisoğlu H., Yıldırır A., Özin B., Uluçam M., Turan M. Carbon coating of stents has no effect on inflammatory response to primary stent deployment. Angiology. 2002 Sep-Oct;53(5):563-8.

Baltali M, Kiziltan HT, Korkmaz M.E., Topçu S, Demirtaş M, Metin M, Topçuoğlu MS, Birand A, Müderrisoğlu H. Prevalence of modifiable cardiovascular risk factors remain high after coronary bypass graft surgery: a multicentre study among Turkish patients. J Cardiovasc Risk. 2002 Aug;9(4):207-14.

Korkmaz M.E., Atar I, Tayfun E, Yildirir A, Ulucam M, Ozin B, Muderrisoglu H, Turan M. Effects of a beta-blocker and spironolactone on plasma homocysteine levels. Int J Cardiol. 2003 Mar;88(1):119-20

Baltali M, Korkmaz M.E., Kiziltan HT, Muderris IH, Ozin B, Anarat R. Association between postprandial hyperinsulinemia and coronary artery disease among non-diabetic women: a case control study. Int J Cardiol. 2003 Apr;88(2-3):215-21.

Korkmaz M.E., Atar I, Tayfun E, Yildirir A, Ulucam M, Ozin B, Muderrisoglu H, Turan M. Effects of a beta blocker and spironolactone on plasma homocysteine levels. Int J Cardiol. 2003 Oct;91(2-3):259-60.

Baltali M, Gokcel A, Kiziltan HT, Korkmaz M.E., Topcu S, Yalcin F, Demircan S, Yigit F, Ozin B, Muderrisoglu IH. Association between the metabolic syndrome and newly diagnosed coronary artery disease. Diabetes Nutr Metab. 2003 Jun;16(3):169-75.

Pirat B, Müderrisoglu H, Korkmaz M.E., Ozin B. Characteristics of coronary heart disease in renal transplant recipients. Transplant Proc. 2004 Jan-Feb;36(1):152-

Baltali M, Kiziltan HT, Korkmaz M.E., Topçu S, Demirtaş M, Müderrisoğlu H, Topçuoğlu S, Birand A. [Metabolic syndrome in patients after coronary bypass surgery: prevalence and compliance with treatment] Anadolu Kardiyol Derg. 2004 Mar;4(1):10-6.

Ozin B, Atar I, Atar IA, Korkmaz M.E., Müderrisoğlu H. An unusual case of right ventricular outflow tract tachycardia. J Interv Card Electrophysiol. 2004 Jun;10(3):261-4.

Yalçin F, Muderrisoglu H, Korkmaz M.E., Ozin B, Baltali M, Yigit F. The effect of dobutamine stress on left ventricular outflow tract gradients in hypertensive patients with basal septal hypertrophy. Angiology. 2004 May-Jun;55(3):295-301.

Ozin B, Borman H, Bozbaş H, Atar I, Korkmaz M.E., Müderrisoglu H. Implantation of submammary implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 1):779-82.

Ulucam M, Yildirir A, Muderrisoglu H, Yakupoglu U, Korkmaz M.E., Ozdemir N, Ozin B, Tayfun E. Effects of hemodialysis on myocardial performance index. Adv Ther. 2004 Mar-Apr;21(2):96-106.

Bozbaş H, Yildirir A, Küçük MA, Ozgül A, Atar I, Sezgin A, Aşlamaci S, Korkmaz M.E., Ozin B, Müderrisoğlu H.Prevalence of coronary artery disease in patients undergoing valvular operation due to rheumatic involvement. Anadolu Kardiyol Derg. 2004 Sep;4(3):223-6.

Bozbas H, Korkmaz M.E., Atar I, Eroglu S, Ozin B, Yildirir A, Muderrisoglu H, Colak T, Karakayali H, Haberal M. Serum levels of cardiac enzymes before and after renal transplantation. Clin Cardiol. 2004 Oct;27(10):559-62.

Pirat B, Korkmaz M.E., Eroğlu S, Tayfun E, Yildirir A, Uluçam M, Ozin B, Müderrisoğlu H.[The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels] Anadolu Kardiyol Derg. 2004 Dec;4(4):318-22.

Yigit F, Muderrisoglu H, Guz G, Bozbas H, Korkmaz M.E., Ozin MB, Tayfun E.Comparison of intermittent with continuous simvastatin treatment in hypercholesterolemic patients with end stage renal failure.Jpn Heart J. 2004 Nov;45(6):959-68.

Atar I, Gülmez O, Atar A, Bozbas H, Yildirir A, Ozin B, Korkmaz M.E., Müderrisoglu H. The effects of prior beta-blocker therapy on serum C-reactive protein levels after percutaneous coronary intervention. Clin Cardiol. 2005 May;28(5):243-6.

Atar I, Korkmaz M.E., Demircan S, Atar IA, Bozbaş H, Aydinalp A, Ozin B, Yildirir A, Müderrisoğlu H. Beta blocker effects on plasma homocysteine levels in patients with hypertension. Atherosclerosis. 2005 Aug;181(2):399-402. Epub 2005 Feb 25.

Ozin B, Sezgin A, Atar I, Gülmez O, Saritaş B, Gültekin B, Korkmaz M.E., Yildirir A, Aşlamaci S, Müderrisoğlu H. Effectiveness of triple-site triggered atrial pacing for prevention of atrial fibrillation after coronary artery bypass graft surgery. Clin Cardiol. 2005 Oct;28(10):479-82.

Heper G, Yorukoglu Y, Korkmaz M.E.. Clinical and hemodynamic follow-up of a patient after operation for dissection of an ascending aortic aneurysm secondary to coarctation of the aorta. Int Heart J. 2005 Nov;46(6):1123-31.

Atar I, Korkmaz M.E., Atar IA, Gulmez O, Ozin B, Bozbas H, Erol T, Aydinalp A, Yildirir A, Yucel M, Muderrisoglu H. Effects of metoprolol therapy on cardiac troponin-I levels after elective percutaneous coronary interventions. Eur Heart J. 2006 Mar;27(5):547-52. Epub 2006 Jan 13.

Yalçın F., Müderrisoğlu H., Korkmaz M.E., Özin B., Baltalı M., Yiğit F. The effect of dobutamine stress on left ventricular outflow tract gradients in hypertensive patients with basal septal hypertrophy. Angiology Yalçin F, Yigit F, Erol T, Baltali M, Korkmaz ME, Müderrisoglu H. Effect of dobutamine stress on basal septal tissue dynamics in hypertensive patients with basal septal hypertrophy. J Hum Hypertens. 2006 Aug;20(8):628-30. Epub 2006 Jun 8.

Bozbas H, Yildirir A, Mermer S, Konas D, Atar I, Aydinalp A, Ozin B, Korkmaz M.E., Muderrisoglu H. Does pravastatin therapy affect cardiac enzyme levels after percutaneous coronary intervention? Adv Ther. 2007 May-Jun;24(3):493-504.

Heper G, Korkmaz M.E. High-pressure pulmonary artery aneurysm and unilateral pulmonary artery agenesis in an adult. Tex Heart Inst J. 2007;34(4):425-30

Heper G, Korkmaz M.E, Kilic A. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction? Angiology. 2007 Dec-2008 Jan;58(6):663-70. Epub 2007 Nov 7.

Bozbaş H, Yildirir A, Pirat B, Eroğlu S, Korkmaz M.E., Atar I, Ulus T, Aydinalp A, Ozin B, Müderrisoğlu H. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis? Anadolu Kardiyol Derg. 2008 Apr;8(2):111-5.

video-player